| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |